Women in the Kentucky area now have an innovative solution for managing heavy periods caused by symptomatic uterine fibroids. Dr. Mark Hoffman and the University of Kentucky have embraced the Sonata Treatment, joining a growing community of physicians offering this minimally invasive alternative to
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that with the support of the American College of